Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 7pembrolizumab 4Ipilimumab 4cemiplimab 3relatlimab 2Watchful Waiting 2Standard of Care 2Specimen Handling 2Prednisone 2Photochemotherapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Dermoscopy 2Cryotherapy 2Carboplatin 2vedolizumab 1trametinib 1toripalimab 1tirbanibulin 1sulforaphane 1gadopiclenol 1famitinib 1decitabine and cedazuridine drug combination 1daromun 1calcipotriene 1anlotinib 1X-Rays 1Vitamin D 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sunscreening Agents × Dermatologic × Clear all
NCT07286318 2026-04-02

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡